This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Onyx Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Alana Lerner: Innovator in Cancer Treatment
Introduction
Alana Lerner is a prominent inventor based in San Francisco, CA, known for her contributions to cancer treatment through innovative research. With a focus on developing effective therapies, she has made significant strides in the field of oncology.
Latest Patents
Alana holds a patent for "Peptide epoxyketone proteasome inhibitors in combination with PIM kinase inhibitors for treatment of cancers." This patent outlines methods for treating cancer in patients using a peptide epoxyketone proteasome inhibitor alongside a PIM kinase inhibitor. Her work aims to enhance the efficacy of cancer treatments and improve patient outcomes.
Career Highlights
Throughout her career, Alana has worked with notable companies such as Onyx Pharmaceuticals, Inc. and Onyx Therapeutics, Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Alana has collaborated with esteemed colleagues, including Shirin Kapur and Christopher J. Kirk. These partnerships have fostered a dynamic environment for innovation and have played a crucial role in advancing her research.
Conclusion
Alana Lerner's dedication to cancer research and her innovative approach to treatment exemplify her commitment to improving healthcare. Her contributions through patents and collaborations continue to make a significant impact in the fight against cancer.